MiroBio Ltd

📍 Oxford, United Kingdom🗓 Founded 2019👥 30 employees💰 Last funded Nov 2021
Biotechnology Research🌐 mirobio.com
Website LinkedIn
Our mission at MiroBio is to deliver transformational immunotherapies for people suffering from autoimmune disease. Immune imbalance is at the heart of many conditions which are marked by an attack on the body’s own cells. MiroBio is advancing a new class of therapies designed to restore immune balance – or homeostasis – and potentially provide durable remission from these chronic, complex conditions. To achieve this, MiroBio has built deep expertise in an emerging area of immunology: precise activation of inhibitory pathways to restore healthy immune function. Our pipeline of agonistic antibodies and supporting platform are informed by over a decade of foundational research. MiroBio draws upon a transatlantic team of advisers, drug developers and leading healthcare investors to further its leadership in this vast new area of immunology.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Belgium
1
Frequently asked questions
Who invested in MiroBio Ltd?
MiroBio Ltd has 1 investors on record on gritt.io, including 1 early-stage backers.
When did MiroBio Ltd last raise funding?
The most recent investment in MiroBio Ltd recorded on gritt.io was in November 2021.
When was MiroBio Ltd founded?
MiroBio Ltd was founded in 2019.
What industry is MiroBio Ltd in?
MiroBio Ltd operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is MiroBio Ltd based?
MiroBio Ltd is headquartered in Oxford, United Kingdom.